Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Graham

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Langmuir : the ACS Journal of Surfaces and Colloids|February 8, 2006
Self-assembled organic monolayers terminated in perfluoroalkyl pentafluoro-lambda(6)-sulfanyl (-SF5) chemistry on goldR Winter, P G Nixon, G L Gard, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 1978
Thyroid function in acute intermittent porphyria: a neurogenic cause of hyperthyroidism?M J Brodie, D J Graham, A Goldberg, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1992
Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitorsJ H Condra, E A Emini, L Gotlib, et al.
The Journal of Biological Chemistry|February 5, 1990
Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cellsJ H Condra, V V Sardana, J E Tomassini, et al.
The Journal of Biological Chemistry|January 5, 1993
Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequenceS S Carroll, D B Olsen, C D Bennett, et al.
The Journal of Infectious Diseases|April 1, 1990
An outbreak of hepatitis A among cancer patients treated with interleukin-2 and lymphokine-activated killer cellsI B Weisfuse, D J Graham, M Will, et al.
The Journal of Biological Chemistry|September 5, 1992
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitorsV V Sardana, E A Emini, L Gotlib, et al.
Nature|April 6, 1995
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsJ H Condra, W A Schleif, O M Blahy, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitroM G Cordingley, R L LaFemina, P L Callahan, et al.
Biochemistry|March 1, 1994
Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding siteV V Sardana, A J Schlabach, P Graham, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Langmuir : the ACS Journal of Surfaces and Colloids|February 8, 2006
Self-assembled organic monolayers terminated in perfluoroalkyl pentafluoro-lambda(6)-sulfanyl (-SF5) chemistry on goldR Winter, P G Nixon, G L Gard, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 1978
Thyroid function in acute intermittent porphyria: a neurogenic cause of hyperthyroidism?M J Brodie, D J Graham, A Goldberg, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1992
Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitorsJ H Condra, E A Emini, L Gotlib, et al.
The Journal of Biological Chemistry|February 5, 1990
Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cellsJ H Condra, V V Sardana, J E Tomassini, et al.
The Journal of Biological Chemistry|January 5, 1993
Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequenceS S Carroll, D B Olsen, C D Bennett, et al.
The Journal of Infectious Diseases|April 1, 1990
An outbreak of hepatitis A among cancer patients treated with interleukin-2 and lymphokine-activated killer cellsI B Weisfuse, D J Graham, M Will, et al.
The Journal of Biological Chemistry|September 5, 1992
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitorsV V Sardana, E A Emini, L Gotlib, et al.
Nature|April 6, 1995
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsJ H Condra, W A Schleif, O M Blahy, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitroM G Cordingley, R L LaFemina, P L Callahan, et al.
Biochemistry|March 1, 1994
Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding siteV V Sardana, A J Schlabach, P Graham, et al.
Pageof 8